Percutaneous tricuspid repair improves severe tricuspid regurgitation
1. In this open-label randomized trial, percutaneous tricuspid transcatheter edge-to-edge repair (TEER) reduced severe tricuspid regurgitation and improved quality of ...
1. In this open-label randomized trial, percutaneous tricuspid transcatheter edge-to-edge repair (TEER) reduced severe tricuspid regurgitation and improved quality of ...
1. A cluster of four cardiac surgery patients were found to have Mycobacterium abscessus infections on the same floor at ...
1. In this randomized clinical trial of 1416 adult cardiac surgery patients, high-dose selenium did not increase the number of ...
1. In this within-trial economic evaluation of the Fibrinogen Replenishment in Surgery (FIBERS) randomized clinical trial, the median total 7-day ...
1. In infants undergoing cardiopulmonary bypass surgery, prophylactic methylprednisolone use did not significantly reduce composite death, heart transplantation, complications, and ...
1. In infants undergoing cardiopulmonary bypass surgery, prophylactic methylprednisolone use did not significantly reduce composite death, heart transplantation, complications, and ...
1. Amongst hospitals with a cardiac surgery department, 11.5% participated actively in research trials of transcatheter mitral or tricuspid therapies. ...
1. In this randomized clinical trial, thrombectomy for stroke due to basilar artery occlusion led to a higher proportion of ...
1. In comparison to the best available medical care, a greater proportion of patients with basilar-artery occlusions achieved good or ...
1. For patients with severe ischemic left ventricular systolic dysfunction on optimal medical therapy, percutaneous coronary intervention (PCI) did not ...
5-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
Monthly plan selected: $4.99 /month.
5-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
Yearly plan selected: $49.90 /year.
2 months free · only $4.16/month
Then $49.90/year. Manage renewal in your account.
Already a member? Sign in